Mar 30, 2017 11:30 am UTC| Business
SAINT-GENIS-POUILLY, France, March 30, 2017 -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), an international specialist in Molecular Nuclear Medicine (MNM), today announced a 10-year...
Mar 30, 2017 11:25 am UTC| Business
Hollywood, March 30, 2017 -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company focused on cannabis (industrial hemp) and cannabinoid research and development,...
Matinas BioPharma Appoints Eric J. Ende, M.B.A, M.D. to its Board of Directors
Mar 30, 2017 11:05 am UTC| Business
BEDMINSTER, N.J., March 30, 2017 -- Matinas BioPharma Holdings, Inc. (NYSE MKT:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today...
Mar 30, 2017 11:03 am UTC| Business
Inivata and Gustave Roussy Publish Positive Results from Prospective Clinical Study in use of ctDNA Liquid Biopsy to Guide Cancer Treatment Publication in Annals of Oncology Shows Benefit of Osimertinib in...
Mar 30, 2017 11:03 am UTC| Business
Inivata and Gustave Roussy Publish Positive Results from Prospective Clinical Study in use of ctDNA Liquid Biopsy to Guide Cancer Treatment Publication in Annals of Oncology Shows Benefit of Osimertinib in...
Mar 30, 2017 11:03 am UTC| Business
Inivata and Gustave Roussy Publish Positive Results from Prospective Clinical Study in use of ctDNA Liquid Biopsy to Guide Cancer Treatment Publication in Annals of Oncology Shows Benefit of Osimertinib in...
Mar 30, 2017 11:02 am UTC| Business
SAN FRANCISCO, March 30, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today announced that clinical results from two Phase 2 studies in China of roxadustat for the treatment of anemia...